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Abstract
Background: Direct allorecognition, i.e., donor lung-derived dendritic cells (DCs) stimulating recipient-derived T
lymphocytes, is believed to be the key mechanism of lung allograft rejection. Myeloid (cDCs) and plasmacytoid
(pDCs) are believed to have differential effects on T cell activation. However, the roles of each DC type on T cell
activation and rejection pathology post lung transplantation are unknown.
Methods: Using transgenic mice and antibody depletion techniques, either or both cell types were depleted in
lungs of donor BALB/c mice (H-2
d) prior to transplanting into C57BL/6 mice (H-2
b), followed by an assessment of
rejection pathology, and pDC or cDC-induced proliferation and cytokine production in C57BL/6-derived mediastinal
lymph node T cells (CD3+).
Results: Depleting either DC type had modest effect on rejection pathology and T cell proliferation. In contrast, T
cells from mice that received grafts depleted of both DCs did not proliferate and this was associated with
significantly reduced acute rejection scores compared to all other groups. cDCs were potent inducers of IFNg,
whereas both cDCs and pDCs induced IL-10. Both cell types had variable effects on IL-17A production.
Conclusion: Collectively, the data show that direct allorecognition by donor lung pDCs and cDCs have differential
effects on T cell proliferation and cytokine production. Depletion of both donor lung cDC and pDC could prevent
the severity of acute rejection episodes.
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Introduction
Lung transplantation is the only therapeutic modality for
many patients with end stage lung disease. However, the
lung is rejected more often than other grafts and the
five year survival is only 50% which is the worst of all
solid organs transplants. Many pathologies contribute to
the graft dysfunction post transplantation and include
primary graft dysfunction (PGD) [1,2], acute rejection
and bronchiolitis obliterans syndrome (BO/BOS). All of
these are believed to have a component of immune
activation resulting in either allo- or autoimmunity that
contributes to graft pathology.
Immune activation post lung transplant may be
mediated by one of three pathways, direct, indirect or
semi-direct [3]. The direct pathway, i.e., mediated by
donor derived DCs interacting with recipient T cells, is
believed to be the predominant pathway involved in
alloimmune activation that leads to rejection in the early
post transplant period. Unlike other solid organ allo-
grafts, the lung is capable of inducing local alloimmune
activation in the absence of any secondary lymphoid
organs. Indeed, studies from Kriesel’sg r o u pd e m o n -
strated direct allorecognition occurs in situ within the
graft as shown by recipient derived T cells interacting
directly with donor derived antigen presenting cells
(APCs) leading to activation of allo-reactive T cells [4].
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the graft or traffic to regional lymphoid tissues such as
the mediastinal lymph nodes [4-7].
While there are multiple types of APCs in the lung,
dendritic cells (DCs), the most potent APCs, are
believed to have key roles in direct allorecognition post
lung transplantation [6,7]. DCs can play a dual role fol-
lowing transplantation; they can induce an alloreactive
response against the allograft; or by contrast, they could
induce donor-specific tolerance [8]. DCs may be divided
into two major subsets, myeloid DCs (cDCs) and plas-
macytoid DCs (pDCs), each are known to have specific
functions in terms of immune activation. Specifically,
cDCs, which are derived from myeloid precursors can
drive a potent Th1 immune response [9]. pDCs, on the
other hand, which are derived from lymphoid precur-
sors, may have roles in immune regulation, including
promoting Th2 driven immune response, as well as
IFN-a driven responses [9]. However, the contribution
of cDCs and pDCs in allorecognition, in general, as well
as post lung transplantation, in particular, are unknown.
I nt h ec u r r e n ts t u d yw eu t i l i z e daB A L B / c( H - 2
d)t o
C57BL/6 (H-2
b) full MHC mismatch transplant model
to assess which APC (cDC or pDC) is responsible for
driving the rejection response. Prior to transplantation,
we depleted cDCs in the donor lung via a DTR Tg
mouse model, or depleted pDCs in the donor lung via a
pDCA-1 antibody, or both cDCs and pDCs, followed by
an assessment of T cell activation, cytokine networks
and rejection pathology.
Materials and methods
Animals
Specific pathogen-free male inbred wild-type (Wt) mice
BALB/c (H2
d) and C57BL/6 (H2
b) were purchased from
Harlan Sprague-Dawley (Indianapolis, IN) C.FVB-Tg
(Itgax-DTR/EGFP)57Lan/J (CD11c-DTR) mice breeder
pairs were purchased from The Jackson Laboratory (Bar
H a r b o r ,M E ) .I nt h e s em i c e ,k n o w na sD T RT g ,t h e
CD11c promoter is under the control of DTR, and will
be referred to as DTR Tg in the current study [10]. The
DTR Tg mice were bred onto a BALB/c backcrossing at
least eight generations. All studies were done in accor-
dance with institutional guidelines of Laboratory Animal
Resource Center at Indiana University School of Medi-
cine. For local DC depletion, Preliminary studies using a
r a n g eo f1 0-5 0 0n gD i p t h e r i aT o x i n - D T / m o u s e
injected intratracheally into DTR Tg mice revealed that
optimal cDC depletion and minimal toxicity occurred
using 50 ng DT/mouse (DT in saline; Sigma-Aldrich,
Inc., St. Louis, MO). For local and systemic depletion of
pDCs mice were injected intraperitoneally with 500 μg/
mouse of anti-mouse PDCA-1 pure functional grade
antibody (Ab) clone JF05-1C2.4.1 (Miltenyi Biotech,
Auburn CA). All donor and recipient mice were 8-12
weeks of age and 24-32 g.
Orthotopic lung transplantation
All surgical procedures were performed utilizing sterile
techniques. A Prescott’s operating microscope (Zeiss
6SFC, Monument, USA) with 20-40× magnification was
used for both donor and recipient operations. Both
donor and recipient were anesthetized with Isoflurane.
The donor®recipient transplanted groups were as fol-
lows: Wt BALB/c®Wt C57BL/6; DTR Tg BALB/c®Wt
C57BL/6; anti-mPDCA-1 Ab injected Wt BALB/c®Wt
C57BL/6; anti-mPDCA-1 Ab injected DTR-Tg BALB/
c®Wt C57BL/6. The donor and recipient surgical pro-
cedures were performed as previously reported [11]. No
mice received any immunosuppressive agents.
Histology
Mice were euthanized by ketamine (50 mg/kg)/xylazine
(10 mg/kg), native and donor lungs harvested, glutaral-
dehyde-fixed, and paraffin embedded. A portion of the
lower lobe of each lung was sectioned and stained with
hematoxylin/eosin. Three to six sections from the lower
lobes of transplanted lungs were examined and grading
of rejection pathology conducted in a blinded fashion
utilizing standard criteria for clinical lung transplanta-
tion [12]. Scoring was focused on the severity of vascu-
lar lesions ("A” scores). A0 = no acute rejection, A1 =
minimal acute rejection, A2 = mild acute rejection, A3
= moderate acute rejection, A4 = severe acute rejection.
Cell Isolation and Characterization
T cells
Single cell suspensions were prepared from the mediast-
inal lymph nodes of transplant recipient mice. T cells
were isolated using CD90.2 (Thy1.2)
+ Microbeads (Mil-
tenyi Biotech, Auburn CA) according manufacturer’s
instructions and were > 98% CD3
+ as reported [13].
Plasmacytoid and Myeloid Dendritic cells
Single cell suspensions were prepared from the lungs of
wild-type BALB/c mice. Plasmacytoid DCs cells were
isolated using anti-mPDCA-1 microbeads and cDCs
were isolated using CD11c microbeads (Miltenyi Bio-
tech, Auburn CA) according manufacturer’s
instructions.
Mixed Leukocyte Reaction (MLR)
Mixed leukocyte reactions were conducted by culturing
irradiated stimulator cells [(3 × 10
4) Wt BALB/c cDC or
pDC] in the in the presence of responder CD3
+ T cells
isolated from the mediastinal lymph nodes of C57BL/6
transplant recipient mice (1 × 10
6/ml) in 96-well plates.
Cultures were pulsed after 48 hr with 1 μCi of [H
3]
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3] thymidine incorporation was
measured 18 hr later.
Cytokine profiling by cytometric bead array (CBA)
Culture supernatants from allograft transplant C57BL/6
recipients were collected and cytokine protein levels of
IL-17A, IL-10, TNF-a,I F N - g, IL-6, and IL-4 were mea-
sured using the Mouse Th1/Th2/Th17 Cytokine Kit (BD
Biosciences, San Jose, CA) according to manufacturer’s
instructions.
Flow cytometry
All staining reactions were performed at 4°C and 2.4G2
Fc receptor Ab (CD16/CD32) was added to reduce non-
specific binding. Lung mononuclear cells were obtained
by homogenizing lungs using the gentle MACS Disso-
ciator (Miltenyi, Auburn, CA) followed by Percoll gradi-
ent purification. The mononuclear cells were stained for
APC subsets using F4/80-APC Cy7 (BM8; Biolegend),
PDCA-1-Alexa Fluor 647 (eBio927; eBioscience),
CD11b-PerCPCy5.5 (M1/70; BD Biosciences), CD11c-PE
Cy7 (HL3; BD Biosciences), B220-PE Cy5 (RA3-6B2; BD
Biosciences), MHC class II-PE (M5/114; eBioscience)
and Gr1-PE (RB6-8C5, BD Biosciences). Cells were fixed
using 1% paraformaldehyde and analyzed using a BD
LSRII Flow Cytometer System. cDCs were defined by
CD11c
+,C D 1 1 b
low,M H Cc l a s sI I
+,B 2 2 0
-,G r 1
-.p D C s
were defined as PDCA
+,C D 1 1 c
low, B220
+,G r 1
-,M H C
class II
+.
Statistical analysis
Statistical analysis was conducted using one-way
ANOVA test and posthoc comparisons using Tukey’s
test for multiple comparisons. Data expressed as means
± Standard Deviation. A “p value” of < 0.05 was consid-
ered significant. All analyses were performed using a
statistics software package (GraphPad Prism 4).
Results
Donor lung cDC or pDC depletion prior to transplantation
With previous reports suggesting that the initiation of
lung rejection may be due to T cell priming in the lung
allograft following transplantation, and with evidence
demonstrating the involvement of dendritic cells (cDCs
and pDCs) in allorecognition, we determined the role of
each DC subset in stimulating alloimmune responses in
T cells. To address this we utilized a full-MHC mis-
match orthotopic transplant model, in which a BALB/c
(H-2
d) donor lung was transplanted into a C57BL/6
recipient (H-2
b [Figure 1A]. This model was chosen due
to the reproducible and robust development of severe
acute rejection (ISHLT Grade A4) within seven days
post transplantation [14]. To examine the role of each
cell subset, we depleted cDCs or pDCs or both cell
types in donor mice prior to harvesting lungs for trans-
plantation. cDCs were depleted using a DTR Tg (BALB/
c) mouse model, in which 50 ng of diphtheria toxin
(DT) was delivered via intratracheal instillation (i.t.)
[Figure 1B]. Two days later, the time at maximal cDC
depletion, the left lung was used as a donor lung and
transplanted into a wildytpe C57Bl/6 mouse. Seven days
later, the mediastinal lymph nodes from the transplant
recipient were harvested and CD3
+ T cells were isolated
and cultured. In complementary studies, pDCs were
depleted using an antibody approach, in which a BALB/
c mouse was injected intraperitoneally with 500 μgo f
anti-mPDCA-1 Ab [Figure 1C] as reported [15]. Three
days later, the time to maximal pDC depletion, the left
lung was transplanted into a wildtype C57BL/6 mouse.
Seven days following, the mediastinal lymph nodes were
harvested from the transplant recipient and CD3
+ T
cells were isolated and cultured. To deplete both sub-
sets, the DTR Tg mice were utilized as the donor and
were given an i.p. injection of 500 μg of anti-mPDCA-1
Ab 3 days prior to transplantation and 50 ng of DT was
given two days prior to transplantation [Figure 1D].
Again, seven days later the mediastinal lymph nodes
were harvested and CD3
+ T cells were isolated and cul-
tured. In all conditions, the transplant recipient was a
C57Bl/6 mouse from which mediastinal lymph node T
cells were purified (CD3
+). pDCs and cDCs utilized for
restimulating T cells ex-vivo were always isolated from
the lungs of normal BALB/c mice and therefore were
d e r i v e df r o mt h es a m es t r a i no fm i c ei nw h i c hD C
depletion occurred.
To verify that cDCs were depleted in the DT treated
DTR Tg donor lung, mononuclear cells were isolated
from the donor treated lungs and assessed for cDCs by
flow cytometry as described in Methods. As shown in
Figure 2A, compared to DT treated Wt BALB/c donor
lungs, a representative DT treated DTR Tg donor lung
showed a 63% reduction in the cDC population, thereby
demonstrating cDC depletion in the donor lung. It is
important to note that in addition to depleting cDCs, in
this DTR Tg mouse model, alveolar macrophages are
also depleted by roughly 50%. F480 staining was utilized
to monitor macrophage depletion during these studies.
To verify pDC depletion in the anti-mPDCA-1 Ab trea-
ted donor lung, lung mononuclear cells were isolated
from the donor treated lungs and assessed for pDCs as
described in Methods. As shown in Figure 2B, compared
t oi s o t y p e( r a tI g G 2 b )t r e a t e dW tB A L B / cd o n o rl u n g s ,
mPDCA-1 Ab treated wildtype BALB/c donor lungs
showed a nearly 84% reduction in the pDC population
in a representative lung, thereby demonstrating pDC
depletion in the donor lung.
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It is unclear as to which DC subset drives the allore-
sponse and which DC is important in inducing T cells
proliferation. With verification of cDC or pDC depletion
in the donor lung prior to transplantation, we next
examined spontaneous T cell proliferation from
untreated Wt allograft recipients, cDC depleted allograft
recipients, pDC depleted allograft recipients or double
depleted (cDC and pDC) allograft recipients. Figure 3A
represents the culture of transplant recipient CD3
+ T
cells alone, in the absence of any stimulation (cDCs or
pDCs). As shown in Figure 3A, T cells from the wild-
type allograft (Wt T) recipient [white bar] spontaneously
proliferate. Additionally, T cells from the DTR Tg
allograft (DTR T) recipient [hatched bar], and T cells
from the mPDCA-1 Ab treated allograft (pDCA1 T)
recipient [gray bar] both spontaneously proliferate, with
the DTR T proliferating significantly more than the Wt
T cells (p < 0.05). Interestingly, T cells from the double
depleted allograft (DTR/pDCA1 T) recipient [black bar]
did not spontaneously proliferate, as compared to the
Wt T cells.
Next, we examined the alloresponsiveness of T cells
from the allograft recipient (C57BL/6-derived) following
restimulation with BALB/c mouse-derived cDCs or
pDCs. These studies would allow for determining which
d o n o rl u n gD Cs u b s e th a dk e yr o l e si np r i m i n go fr e c i -
pient T cells. To assess this, allograft recipient
Figure 1 cDC and/or pDC depletion setup in murine orthotopic transplant model. Donor ®recipient transplanted groups: Wt BALB/c®Wt
C57BL/6; DT (50 ng) injected DTR-Tg BALB/c®Wt C57BL/6; anti-mPDCA-1 Ab (500 ng) injected Wt BALB/c®Wt C57BL/6; anti-mPDCA-1 Ab (500
ug) and DT (50 ug) injected DTR-Tg BALB/cc®Wt C57BL/6. N = four to six mice per group.
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Page 4 of 10Figure 2 Verification of cDC or pDC depletion by flow cytometry. Lung mononuclear cells were stained for DC subset markers. Cells are
reported as percent of total population. Macrophages were excluded using FL1 autofluorescence and the macrophage specific marker F4/80. A)
Myeloid dendritic cells: B220
-, Gr1
-, CD11b
+ and CD11c
+. Wt BALB/c + DT (non-depleted control) vs. DTR Tg BALB/c + DT (depleted) yield a 63%
depletion. B) Plasmacytoid dendritic cells: CD11clow, B220
+, and PDCA
+. Wt + isotype Ab (non-depleted control) vs. Wt Balb/c + mPDCA-1 Ab
(depleted) yields a 84% depletion. Data are representative of four to six mice in each group.
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Page 5 of 10Figure 3 T cell alloreactivity in response to cDC or pDC stimulation.L u n gt r a n s p l a n t a t i o nw a sp e r f o rmed as described in Methods and
transplanted lungs harvested at 7 days post transplant. A-D) Mediastinal lymph node CD3+ T cells from lung transplant recipient (C57BL/6) mice
were cultured alone (3 × 10
5) or in the presence of Wt donor (BALB/c)-derived cDCs or pDCs (3 × 10
4). Cells were incubated for 72 h at 37°C. T-
cell proliferation was measured by 3H thymidine incorporation. A) Spontaneous T cell proliferation of Wt, DTR, PDCA1 and DTR/pDCA1 transplant
groups. B) cDC and pDC were co-cultured with Wt T cells isolated from lung transplant recipients that received dendritic cell sufficient lung
allografts. C) cDC and pDC co-cultured with recipient-derived T cells isolated from cDC, pDC or cDC/pDC depleted transplant groups. D) pDC
and cDC co-cultured with recipient-derived T cells isolated from cDC and pDC depleted transplant groups. Responses of recipient cells were
compared using one-way ANOVA analysis. ** p < 0.01, # p = 0.01, ## p = 0.02 * p < 0.05 Panels E-H represent H&E stained lung sections from
allografts harvested at day 7. Table 2) Histologic rejection scores for transplant groups. Data represent the mean +/- SD of “A” scores for four to
six mice in each group harvested at 7 days. *p < 0.05 compared to other groups. (40× magnification).
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+ Tc e l l sw e r ec o - c u l t u r e d
with lung-derived cDCs or pDCs. Due to the limitations
in acquiring large enough numbers of cDCs, and pDCs
from the transplanted mice for the purposes of multiple
co-cultures with the CD3
+ recipient T cells, we chose
take a different approach. In each co-culture condition,
wild-type lung-derived BALB/c cDCs or pDCs were iso-
lated and co-cultured with the various transplant recipi-
ent CD3
+ mediastinal lymph node T cells; T cell
proliferation was then assessed [Figure 3B-D].
In panel B of Figure 3, we examined the response of
Wt T cells to cDCs or pDCs. As compared to the spon-
taneous proliferation of the Wt T cells alone, when
BALB/c-derived cDCs or pDCs were co-cultured with
Wt T cells from normal C57BL/6 mice, the cells did not
proliferate briskly. Moreover, when recipient T cells
from the DT treated DTR allograft (cDC depleted) were
restimulated with BALB/c-derived cDCs, there was no
significant change in proliferation as compared to T
cells alone [Figure 3C, hatched bar]. Interestingly, when
recipient T cells from mPDCA-1 treated allograft (pDC
depleted) were restimulated with BALB/c-derived pDCs,
they proliferated less, as compared to the spontaneously
T cells from pDCA1-treated mice [Figure 3C, gray bar].
When BALB/c-derived cDCs or pDCs were used to res-
timulate recipient T cells from the double DC-depleted
allograft recipients, there was a significant increase in
proliferation as compared to unstimulated T cells alone
[Figure 3C, black bars]. When BALB/c-derived pDCs
were used to restimulate T cells (C57BL/6) from DT
treated DTR mice lung transplant recipients, there was
a significant increase in proliferation compared to the
spontaneously proliferating DTR T cells [Figure 3D,
hatched bar]. Lastly, when T cells from pDC-depleted
lung transplant recipients were restimulated with BALB/
c cDCs, there was no change in proliferation when com-
pared to the spontaneously proliferating pDCA1 T cells
[Figure 3D, gray bar]. Collectively, these data suggest
that both cDC and pDC in the donor lung contribute to
alloantigen-induced priming of recipient T cells. How-
ever, donor lung-derived pDCs appear to more potent
than cDCs in alloantigen-induce priming post lung
transplantation.
Lung allograft rejection is believed to be initiated by
donor derived lung DCs activating recipient T cells.
Data showing that lymph node T cells from mice that
had lungs depleted of both cDCs and pDCs did not
spontaneously proliferate (Figure 3A) could suggest that
depletion of both cDCs, pDCs, or both may prevent or
down regulate rejection pathology. Using standard rejec-
tion pathology criteria [12] we examined the histology
in the BALB/c®C57BL/6 full mismatch model. All
untreated transplanted lungs had undergone severe
acute rejection (Grade A4) within seven days post
transplantation [Figure 3E]. cDC depletion in the allo-
graft lung, DTR(DT) BALB/c®C57BL/6, slightly
decreased acute rejection [Figure 3F]. pDC depletion in
the allograft lung, mPDCA-1 Ab BALB/c®C57BL/6,
resulted in a similar decrease in acute rejection com-
pared to cDC depletion [Figure 3G]. However, double
depletion, DTR/mPDCA1, significantly decreased acute
rejection even further as compared to all other groups
[Figure 3H] (p < 0.05).
cDC or pDC-induced cytokine production
With data demonstrating that pDCs may be important
for initiating the alloimmune response, we next deter-
mined spontaneous, pDC or cDC-induced cytokine pro-
duction-derived from mediastinal lymph node T cells
isolated from lung transplant recipients. Cytokine pro-
files were assessed within the supernatants from the co-
culture experiments shown in Figure 3. Figure 4 data is
shown to match the groups show in the proliferation
studies of Figure 3. Spontaneously proliferating recipient
T cells from each condition secreted low or non-detecti-
ble levels of IFN-Y, and neither BALB/c cDC nor pDC
induced IFN-Y from wildtype T cells (CD3+) isolated
from normal C57BL/6 mice [Figure 4A]. Notably, recipi-
ent T cells produced IFN-g when either cDC, pDCs or
b o t hw e r ed e p l e t e df r o mt h eg r a f tp r i o rt ot r a n s p l a n t a -
tion (Figure 4A). However, cDCs appear to have a major
role in IFNg induction since IFN-g responses were most
robust in T cells isolated from mice that received lungs
depleted of pDCs and restimulated with cDCs (Figure
4 A ) .T h e s ed a t as u g g e s tar o l ef o rd o n o rl u n g - d e r i v e d
cDC in stimulating IFN-g production. These data are
consistent with the known role of cDCs in the induction
of Th1 (IFN) responses [16].
T cell cultures revealed low level IL-6 production,
constitutively. Since IL-6 is made by mononuclear cells,
other than T cells, then this production could have been
due to the presence of non-T cells in the cultures (Fig-
ure 4B). However, T cells may induce DCs to produce
IL-6. Interestingly, very low levels of IL-6 were detected
in the co-cultures of cDCs or pDCs with wildtype
lymph node T cells [Figure 4B]. In contrast, IL-6 was
detected in co-cultures in which T cells had been
primed with cDCs, pDCs, or severely reduced popula-
tions of both cDC and pDC (cDC + DTR T, cDC +
pDCA T, or cDC + DTR/pDC T groups) (Figure 4B).
Depletion of cDCs resulted in significantly greater
spontaneous IL-10 production from recipient T cells
(DTR T group) as compared to wildtype T cells or T
cells isolated from lung allograft recipients depleted of
pDCs or both cDCs and PDCs (Figure 4C), These data
could suggest pDC may have a role in stimulating IL-10
production from recipient T cells, and could be consis-
tent with reports demonstrating that pDCs can promote
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Page 7 of 10regulatory T cell (Treg) development, which is in part
characterized by expression of CD4+Foxp3+ in T cells
[17]. However, the highest level of IL-10 was induced by
cDCs in co-culture with T cells from pDC-depleted
lung allograft recipients (cDC + pDCA T). Furthermore,
pDCs and cDCs appear comparable in stimulating IL-10
production from mice that received lungs deficient in
cDCs (cDC + DTR T, and pDC + DTR T groups), [Fig-
ure 4C]. Collectively, these data suggest a complex rela-
tionship of cDC or pDC-alloantigen induced IL-10
production from recipient T cells.
Similar to IL-10, depletion of cDCs resulted in signifi-
cantly greater spontaneous IL-17A production from
recipient T cells (DTR T group) as compared to wild-
type T cells or T cells isolated from lung allograft recipi-
ents depleted of pDCs or both cDCs and PDCs [Figure
4D]. In general, the production of IL-17A from T cells
[Figure 4D] followed the same patterns as shown for IL-
10 [Figure 4C]. One exception is data showing that
pDCs, in contrast to cDCs, were not able to induce any
IL-17A production from mice that received lungs
deficient in both cDC and pDCs. These data could also
be explained by pDC-induced suppression of IL-17A
production. Neither TNF-a nor IL-4 were detected at
significant levels in any assay condition (data not
shown).
Discussion
Dendritic cells (DC) are the most potent APCs in regu-
lating adaptive immune responses. As such, DCs have
been reported to have important/dual roles in regulating
alloimmunity leading to either transplant rejection or
tolerance. Since lung allograft rejection is thought to be
initiated by donor derived lung DCs activating recipient
T cells, we examined the role of donor-derived DC sub-
sets (cDCs and pDCs) in stimulating the responsiveness
of recipient T cells. In this study we demonstrated that
depletion of both donor allograft cDCs plus pDCs down
regulated the pathology of lung allograft rejection.
Furthermore, T cells isolated from mice that received
lungs depleted of both cDCs and pDCs did not sponta-
neously proliferate, as compared to T cells from mice
A. B.
C. D.
Figure 4 Cytokine production in response to cDC or pDC stimulation. Mediastinal lymph node CD3
+ T cells from lung transplant recipient
(C57BL/6) mice were cultured alone (3 × 10
5) or in the presence of Wt donor (BALB/c)-derived cDCs or pDCs (3 × 10
4). Cells were incubated for
72 h at 37°C. Culture supernatant was collected and A) IFN-g, B) IL-6, C) IL-10, and D) IL-17A were measured by cytometric bead assay. * p <
0.01, # p < 0.05 compared to cDC + Wt T and pDC + Wt T groups by one-way ANOVA with Dunnett’s Multiple Comparison post-test.
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our assessment of T cell priming, we demonstrated that
although both cDC and pDC in the donor lung contri-
bute to alloantigen-induced priming of recipient T cells,
donor lung-derived pDCs appear to be more potent
than cDCs in alloantigen-induced proliferation, whereas
donor lung-derived cDCs were potent inducers of IFN-g
responses.
Maturation status has been linked to the ability of
D C st oi n d u c eo rs u p p r e s si m m une responses. Specifi-
cally, immature DCs may be suppressive/tolerogenic
whereas mature DCs may be highly immunogenic [16].
However, DC immunogenicity may also be linked to
specific subsets. cDCs and PDCs comprise two major
groups of DCs in all tissues [18]. In the context of
organ transplantation, cDCs are reported to be highly
immunogenic and efficient in stimulation anti-T cell
alloimmunity, including production of IFN-g [19]. In
contrast, pDCs have been reported to be tolerogenic
[20]. Specifically, suppression of alloreactive T cell via
induction of regulatory T cells or clonal deletion of
alloreactive T cells have been functions ascribed to
pDCs [21]. pDCs may be responsible for suppressing
activation and proliferation of alloreactive T cells via
induction of T regulatory cells (Tregs), inhibiting mem-
ory T cell responses or clonal deletion, thereby promot-
ing tolerance and preventing graft rejection in non-
pulmonary allografts [14-16,22-24]. Consistent with
prior reports in other organs, the current study shows
that lung cDCs are potent inducers of IFN-g production,
and contribute to induction of IL-10. However, pDCs
did not appear to be tolerogenic as shown by studies in
which cDC depletion did not lead to improved out-
comes histologically. Abe et al., reported that pDCs pro-
pagated from donor or third-party bone marrow could
prolong murine cardiac allograft survival [22]. In
another study, host-derived pDCs played an important
role in development of allograft tolerance. In this study,
host-derived pDCs acquired donor antigens from the
allograft and migrated to the lymph node, where they
induced alloantigen-specific Tregs, which lead to the
induction of tolerance. Depletion of pDCs in this model,
inhibited Treg development and the induction of toler-
ance [24]. Similar findings have been reported in human
liver transplant studies [17]. In contrast, depletion of
both cDC and pDC resulted in diminished spontaneous
T cell proliferation and prevented rejection pathology.
These data highlight a role for both lung cDCs and
pDCs in initiating allo-responsiveness post lung trans-
plantation. The differences in the potential roles of
pDCs in tolerance and immunogenicity in the current
study could be related to the fact that lung-derived DCs
are phenotypically and functionally distinct from other
tissue-derived DCs [25]. Accordingly, data derived from
a non-pulmonary transplant models are not likely to be
extrapolated to, or reproduced in the lung.
In our model, we utilized naïve cDCs and pDCs as sti-
mulators in the presence of recipient T cells. Since
cDCs and pDCs make up less than 1% of the total cell
population in the lung, we were not able to isolate suffi-
cient allograft cDCs or pDCs to use for ex vivo stimula-
tion. Doing so would have allowed us to examine the
function of DCs conditioned by the allograft environ-
ment in stimulating T cells. However, this assessment
would have required transplanting and harvesting more
donor and recipient allografts than could be performed
in an individual experiment. Another aspect that could
have impacted our results examining T cell activation is
effect of donor lung-derived non-professional APCs,
such as epithelial [26,27] and endothelial [28] cells in
stimulating T cells.
Conclusion
These data highlight the importance of both DC subsets
in initiating alloimmune responses post lung transplan-
tation. A limitation of the data presented is that there
were residual cDC and pDC in depleted mice as has
been reported by other using these techniques [10].
Accordingly, some observed effects could have been to
due residual cells of each type in treated mice, or possi-
bly due to effects mediated by recipient DCs [29].
Although it has been thought that pDCs are required to
promote tolerance and prolong allograft survival, it
appears that the absence of both cell subsets contribute
to alloimmune activation. Therefore, it is interesting to
speculate that depletion of both pre-transplant could
lead to diminished acute rejection episodes.
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